Shinpoong Pharmaceutical Co.,Ltd

KOSE:A019170 Stock Report

Market Cap: ₩557.7b

Shinpoong PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 6/6

Shinpoong PharmaceuticalLtd has a total shareholder equity of ₩268.7B and total debt of ₩44.0B, which brings its debt-to-equity ratio to 16.4%. Its total assets and total liabilities are ₩340.8B and ₩72.2B respectively.

Key information

16.4%

Debt to equity ratio

₩44.00b

Debt

Interest coverage ration/a
Cash₩59.08b
Equity₩268.68b
Total liabilities₩72.15b
Total assets₩340.83b

Recent financial health updates

Recent updates

Does Shinpoong PharmaceuticalLtd (KRX:019170) Have A Healthy Balance Sheet?

Nov 13
Does Shinpoong PharmaceuticalLtd (KRX:019170) Have A Healthy Balance Sheet?

Shinpoong Pharmaceutical Co.,Ltd's (KRX:019170) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Sep 11
Shinpoong Pharmaceutical Co.,Ltd's (KRX:019170) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Is Shinpoong PharmaceuticalLtd (KRX:019170) Weighed On By Its Debt Load?

Aug 08
Is Shinpoong PharmaceuticalLtd (KRX:019170) Weighed On By Its Debt Load?

Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Apr 24
Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?

Mar 07
Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?

Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?

Feb 01
Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?

We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide

Jan 05
We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide

Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?

Dec 10
Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?

Financial Position Analysis

Short Term Liabilities: A019170's short term assets (₩194.3B) exceed its short term liabilities (₩69.4B).

Long Term Liabilities: A019170's short term assets (₩194.3B) exceed its long term liabilities (₩2.8B).


Debt to Equity History and Analysis

Debt Level: A019170 has more cash than its total debt.

Reducing Debt: A019170's debt to equity ratio has reduced from 49.8% to 16.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: A019170 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: A019170 has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 40.2% each year.


Discover healthy companies